Hospice Commodification and the Limits of Antitrust

As hospice care is increasingly dominated by private equity firms, an antitrust response, while necessary, has the potential to normalize the language of the market as the default mode for discussing healthcare reform. Hospice demonstrates what is lost when healthcare is described as a mere economic.